
SMSLIFE Latest Share Price (SMSLIFE)
TODAY IN ONE LINE
it trades at a P/E of N/A. Track live valuations, technical indicators, and peers comparison below. Check delivery conviction and recent filings to build your view.
How good is this company?
Overall performance across 5 key dimensions.
SMSLIFE flags & news
Key strengths, potential risks, and recent updates.
Green Flags
- ●Strong Price MomentumRobust returns of 32.7% over 1Y
- ●Virtually Debt-FreeVery low Debt-to-Equity of 0.00x
- ●Zero Pledge RiskNo recent active promoter pledging found
Red Flags
- ●Earnings DeclineEPS (TTM) has contracted by 3.4% YoY
- ●Rising Receivables vs SalesReceivables grew 34.4% outpacing sales growth of 12.7%
Latest SMSLIFE News
What changed recently?
Recent events, corporate actions, and announcements.
SMSLIFE valuation: P/E, P/B and sector benchmarks.
Twelve years of multiples investors have paid for SMSLIFE, framed against the sector median so the premium or discount is obvious at a glance.
Market-priced ratios use the latest available quote; accounting metrics use the latest reported filing. Compare values with matched peers and the company's own history.
Valuation
Profitability
Growth
Financial Health
SMSLIFE technical analysis: indicators, pivots and CPR.
Latest RSI, MACD and moving-average signals plus the latest pivot and Central Pivot Range levels for SMSLIFE — derived from the latest tape, not yesterday's close.
SMSLIFE last traded at ₹1,380.1 with an intraday range of ₹1,338–₹1,430 — latest indicator, pivot and CPR signals below.
Pivot points
Standard pivot — most widely referenced.
Pivot levels · Classic
Last: ₹1380.10| Level | Price (₹) | Distance | % Δ |
|---|---|---|---|
| R4 | 1611.40 | +231.30 | +16.76% |
| R3 | 1519.40 | +139.30 | +10.09% |
| R2 | 1474.70 | +94.60 | +6.85% |
| R1 | 1427.40 | +47.30 | +3.43% |
| PIVOT | 1382.70 | 2.60 | 0.19% |
| CURRENT | 1380.10 | — | — |
| S1 | 1335.40 | -44.70 | -3.24% |
| S2 | 1290.70 | -89.40 | -6.48% |
| S3 | 1243.40 | -136.70 | -9.91% |
| S4 | 1151.40 | -228.70 | -16.57% |
SMSLIFE is trading Below CPR, indicating Bearishness
CPR is Average
Day's range: ₹–₹
Trading Inside opening range
SMSLIFE financials: P&L, balance sheet, cash flow, ratios.
Reported annual and quarterly results for SMSLIFE — consolidated or standalone — with margins, YoY growth and key ratios inline.
SMSLIFE segment analysis : revenue and profit mix.
Disclosed business segments at SMSLIFE with their share of revenue and profit, switchable between consolidated and standalone reporting.
SMSLIFE discloses revenue and profit across multiple business segments — toggle between consolidated and standalone views to see the mix.
Segment-wise Financial Analysis
The Bull, Bear, and Flip case for SMSLIFE.
Our AI distills the core fundamental drivers supporting SMSLIFE, the risks that threaten it, and the quantitative conditions that could weaken the thesis.
SMSLIFE's investment case rests on 10 positive markers and 10 flagged concerns drawn from the latest reported filings.
What you're getting.
Strong promoter confidence evidenced by increased holding to 71.40% by March 2025.
P/E ratio of 19.10 is slightly below sector average, suggesting potential undervaluation.
Trades at reasonable 1.99x Price-to-Book value (650.15), offering investor cushion.
Impressive 5-year EPS growth of 14.41% demonstrates consistent earnings capability.
Consistent 5-year revenue growth of 5.74% indicates stable market presence.
Key Risks.
Latest quarterly net profit declined significantly by 49.66%, raising profitability concerns.
Extremely low Return on Equity (3.98%) indicates poor efficiency in capital utilization.
ROCE of 11.80% is significantly lower than peers, suggesting operational inefficiency.
Negligible FII/DII holdings (0.00-0.02%) indicate lack of institutional investor confidence.
Negative 3-year EPS growth of -7.34% indicates recent earnings contraction.
Flip Conditions.
Reassess if quarterly profit growth turns negative for two consecutive quarters. The bull case relies on compounding earnings.
SMSLIFE peer comparison — same-sector benchmarks.
No comparable peer set was disclosed for SMSLIFE.
Peer comparison data is not available.
SMSLIFE chart patterns: breakouts, tops and bottoms.
Auto-detected classical chart patterns for SMSLIFE — Double Top/Bottom, Head & Shoulders, Triple Bottom and more — with break levels, targets and quality scores across Intraday, Daily and Weekly timeframes.
SMSLIFE delivery volume — last 20 sessions of conviction.
Daily traded volume and delivery percentage for SMSLIFE over 20 sessions — the gap between intraday flipping and genuine accumulation.
Latest session delivery in SMSLIFE stood at 71.4% of traded volume, against a 20-day average of 73.5%.
SMSLIFE announcements: results, concalls, ratings, M&A.
Filings SMSLIFE sent to the exchanges, sequenced as they hit the tape — concall transcripts, results, credit ratings and presentations.
No filings or concall transcripts on record.
SMSLIFE dividend history, splits and bonus issues.
Every dividend, stock split and bonus issue SMSLIFE has declared, sequenced by announce and record date.
SMSLIFE corporate-action history below covers all declared dividends, stock splits and bonus issues recorded with NSE and BSE.
SMSLIFE insider trading: promoter and management activity.
Promoter, director and designated-employee transactions in SMSLIFE as reported to SEBI — buying and selling signals from the people who know the business best.
SMSLIFE insider activity below tracks 3 reported promoter, director and designated-employee transactions under SEBI Regulation 7(2).
| Insider | Category | Txn Date | Action | Quantity | Value (₹) | Price |
|---|---|---|---|---|---|---|
| TV Praveen | Insider | 18 Mar 2025 | buy | +1.21 L | ₹12.81 Cr. | ₹1,062.15 |
| T V V S N MURTHY (HUF) | Insider | 18 Mar 2025 | sell | −2.41 L | ₹25.62 Cr. | ₹1,062.15 |
| Sudeepthi Gopineedi | Insider | 18 Mar 2025 | buy | +1.21 L | ₹12.81 Cr. | ₹1,062.15 |
About SMSLIFE: business, sector, key facts.
What SMSLIFE does, where it operates, the people running it, and the numbers that describe the entity behind the ticker.
SMSLIFE operates in the Pharmaceuticals industry under the Healthcare sector, listed as NSE: SMSLIFE, BSE: 540679.

SMS Lifesciences India Limited is a prominent Indian manufacturer and exporter of active pharmaceutical ingredients (APIs) and intermediates. Their business model centers around supplying crucial components used in the production of various pharmaceutical drugs, playing a significant role in the global pharmaceutical supply chain. The company has established a considerable presence within the Indian market and actively participates in international trade.
The company's product portfolio spans a wide range of therapeutic areas. They produce APIs for treatments addressing diverse medical conditions, including ulcers, erectile dysfunction, gout, infections, obesity, fungal infections, convulsions, nausea, ophthalmic issues, parasitic infestations, and more. This breadth of therapeutic applications demonstrates their versatility and capacity within the API market. Beyond their existing API offerings, SMS Lifesciences is actively engaged in research and development, focusing on expanding their capabilities into areas such as antidepressants, antipsychotics, antihypertensives, veterinary pharmaceuticals, antivirals, and anticoagulants.
In addition to APIs, SMS Lifesciences manufactures and supplies intermediates, which are the precursor chemicals used in the synthesis of APIs. The range of intermediates they offer mirrors the diversity found in their API portfolio, supporting the production of medications for similar therapeutic areas. This integrated approach, encompassing both APIs and intermediates, allows for greater control over the supply chain and potential cost efficiencies.
Established in 1990 and headquartered in Hyderabad, India, SMS Lifesciences has cultivated a significant amount of experience in the pharmaceutical industry. Their commitment to research and development, alongside their diversified product offerings, positions them for continued growth and expansion within the competitive global API market. Their export activities highlight their ambition to serve a wider international customer base and contribute to global healthcare.
Related
Peers, sector trends, screeners and strategy playbooks contextual to this stock.
Questions investors ask about SMSLIFE (SMSLIFE).
Quick answers grounded in this page's data — price action, fundamentals, ratios and ownership.
01What is the current share price of SMSLIFE (SMSLIFE)?
The current share price of SMSLIFE (SMSLIFE) is ₹1,380.10. Today, the stock has gained by ₹26.60 (1.97%), trading in a range of ₹1,338.00 to ₹1,430.00. The stock opened at ₹1,384.00 with a trading volume of 3,713 shares.
02What is the 52-week high and low price of SMSLIFE stock?
The 52-week high price of SMSLIFE (SMSLIFE) is ₹1,539.00, while the 52-week low is ₹1,290.00. Currently trading at ₹1,380.10, the stock is 6.98% above its 52-week low and 10.32% below its 52-week high. These levels help investors understand the stock's price volatility and trading range over the past year.
03What is the dividend yield of SMSLIFE and when is the next dividend?
SMSLIFE offers a dividend yield of 0%, which means for every ₹100 invested at the current price of ₹1,380.10, you can expect to receive approximately ₹0.00 annually as dividends. For information about the next dividend announcement and ex-dividend date, please check the company's official announcements or visit the BSE/NSE websites.
04How is SMSLIFE stock performing today in the market?
SMSLIFE stock opened at ₹1,384.00 and is currently trading at ₹1,380.10, showing a gain of ₹26.60 (1.97%). The intraday high is ₹1,430.00 and low is ₹1,338.00. The trading volume stands at 3,713 shares, indicating moderate market participation today.
05What is the market capitalization of SMSLIFE?
SMSLIFE has a market capitalization of ₹0, making it a small-cap company. Market cap is calculated by multiplying the current stock price (₹1,380.10) by the total number of outstanding shares. This metric helps investors understand the company's size, stability, and investment risk profile.
06What is the ROE and ROCE of SMSLIFE?
SMSLIFE has a Return on Equity (ROE) of 0% and Return on Capital Employed (ROCE) of 0%. ROE measures how efficiently the company generates profits from shareholders' equity, while ROCE indicates how well the company uses its capital to generate profits. These returns may need improvement for better profitability. Higher percentages generally indicate better financial performance.
07Which sector and industry does SMSLIFE belong to?
SMSLIFE operates in the Healthcare sector and belongs to the Pharmaceuticals industry. The company competes with other players in this space and its performance is influenced by sector-specific trends, regulatory changes, and market dynamics. Understanding the sector helps investors assess growth potential, cyclical patterns, and industry-specific risks that may impact the stock's performance.
08What is the sales and profit growth of SMSLIFE?
SMSLIFE has reported a sales growth of 3.34% and profit growth of 0%. The company may be facing growth challenges or operating in a mature market. Consistent growth over multiple quarters is a positive indicator for long-term investors. Compare these growth rates with industry peers for better perspective.
The data, ratios and commentary about SMSLIFE (SMSLIFE) on this page are published for educational and informational purposes only and are not investment, legal or tax advice. StockeZee is not a SEBI-registered investment adviser, research analyst or portfolio manager, and no content here should be construed as a recommendation to buy, hold or sell any security. Live and historical market data may be delayed, revised by the exchanges, or contain errors; figures sourced from third-party feeds and corporate disclosures may not always be current. Past performance is not indicative of future results, and equity investments carry the risk of capital loss. Before acting on anything you read here, please consult a SEBI-registered financial advisor and read all scheme-related documents carefully.